Učitavanje...
Cell therapy for peripheral artery disease
Patients with severe peripheral artery disease (PAD) who are not candidates for revascularization have poor prognosis. Cell therapy using peripheral blood- or bone marrow-derived mononuclear cells, mesenchymal stem cells, or marker-specific subsets of bone marrow cells with angiogenic properties may...
Spremljeno u:
| Izdano u: | Curr Opin Pharmacol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019642/ https://ncbi.nlm.nih.gov/pubmed/29452987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2018.01.005 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|